Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 10;17(1):sfad257.
doi: 10.1093/ckj/sfad257. eCollection 2024 Jan.

Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort

Serafí Cambray  1   2 , Marcelino Bermúdez-López  1   3 , Alicia Garcia-Carrasco  1 , Jose M Valdivielso  1 ; NEFRONA investigators
Collaborators, Affiliations

Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort

Serafí Cambray et al. Clin Kidney J. .

Abstract

Background: Chronic kidney disease (CKD) is associated with increased atherosclerotic burden and higher risk for cardiovascular events (CVE). Atherosclerosis has a significant genetic component and, in CKD, it is influenced by mineral metabolism alterations. Therefore, genetic modifications of mineral metabolism-related proteins could affect atherosclerosis in CKD patients. In the present study we investigated the role of single nucleotide polymorphisms (SNPs) of the matrix gamma-carboxy glutamic acid protein (MGP) on atherosclerosis progression and CVE in a CKD cohort.

Methods: A total of 2187 CKD patients from the Observatorio Nacional de Aterosclerosis en Nefrologia (NEFRONA) study were genotyped for SNPs present in the matrix gamma-carboxy glutamic acid (Gla) protein (MGP) gene. Atheromatosis was detected by vascular ultrasound. Progression of atheromatosis, defined as an increase in territories with plaque, was assessed after 24 months. Patients were followed for 48 months for CVE. Association of SNPs with plaque progression was assessed by logistic regression and their capacity to predict CVE by Cox regression.

Results: Three SNPs of the MGP gene were analyzed. No association of the rs4236 or the rs1800801 SNPs was detected with any of the outcomes. However, patients homozygotes for the minor allele of the rs1800802 SNP showed higher adjusted risk for plaque progression [odds ratio 2.3 (95% confidence interval 1.06-4.9)] and higher risk of suffering a CVE [hazard ratio 2.16 (95% confidence interval 1.13-4.12)] compared with the rest of genotypes. No association of the SNP with total or dp-ucMGP levels was found in a subsample.

Conclusions: The rs1800802 polymorphism of MGP is associated with plaque progression and CVE in CKD patients.

Keywords: atherosclerosis progression; cardiovascular events; chronic kidney disease; matrix gamma-carboxy glutamic acid (Gla) protein; polymorphisms.

PubMed Disclaimer

Conflict of interest statement

J.M.V. is member of the CKJ Editorial Board.

Figures

Graphical Abstract
Graphical Abstract
Figure 1:
Figure 1:
Kaplan–Meier curves showing the incidence of cardiovascular events depending on genotype during the follow-up period. Log-rank test comparing the survival distributions showed significant differences (P-value = 0.005).
See this image and copyright information in PMC

References

    1. GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet North Am Ed 2020;396:1204–22. 10.1016/S0140-6736(20)30925-9 - DOI - PMC - PubMed
    1. Foreman KJ, Marquez N, Dolgert Aet al. . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet North Am Ed 2018;392:2052–90. 10.1016/S0140-6736(18)31694-5 - DOI - PMC - PubMed
    1. Matsushita K, van der Velde M, Astor BCet al. . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073–81 - PMC - PubMed
    1. Jankowski J, Floege J, Fliser Det al. . Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 2021;143:1157–72. 10.1161/CIRCULATIONAHA.120.050686 - DOI - PMC - PubMed
    1. Valdivielso JM, Rodríguez-Puyol D, Pascual Jet al. . Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol 2019;39:1938–66. 10.1161/ATVBAHA.119.312705 - DOI - PubMed